An in vitro assessment of determinants of susceptibility of mouse bone marrow stromal cells to hydroquinone-induced toxicity.
Authors
Twerdok LE; Rembish SJ; Trush MA
Source
Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 1990 Jan; :1-7
Link
NIOSHTIC No.
00234742
Abstract
Primary stromal cells from BDA/2-mice were characterized, and the reduction in their ability to support granulopoiesis after exposure to the benzene (71432) metabolite hydroquinone (123319) (HQ) was studied. Bone marrow cells were harvested from male BDA/2-mice and used to establish a primary adherent stromal cell culture. The cell population was stable at 60% macrophages as determined by esterase staining 7 and 14 days after isolation. Quinone-reductase (QR) activity of the stromal cells assayed over the same period was also stable at approximately 30 nanomoles/minute/milligram protein. The effect of HQ induced toxicity on stromal cell supported granulopoiesis was assayed by granulocyte/monocyte colony formation. A significant reduction was seen in the number of colonies formed when bone marrow cells were cultured in conditioned media from stromal cells exposed for 12 days to a subtoxic concentration of 15 micromolar (microM) HQ compared to cells cultured in conditioned media from unexposed stromal cells. When stromal cells were pretreated with 75microM 1,2-dithiole-3-thione (DTT) for 24 hours prior to HQ treatment, no reduction in colony formation was observed, indicating no loss of stromal cell supported granulopoiesis. The authors conclude that BDA/2-mice stromal cell cultures are stable with respect to population composition and QR activity over the 14 period studied, that HQ induces reduction of stromal cell supported granulopoiesis, and that DTT affords protection against this aspect of HQ toxicity.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.